Journal of International Obstetrics and Gynecology ›› 2022, Vol. 49 ›› Issue (2): 196-201.doi: 10.12280/gjfckx.20210573
• Research on Gynecological Malignancies:Review • Previous Articles Next Articles
Received:
2021-06-18
Published:
2022-04-15
Online:
2022-05-09
Contact:
LI Pu
E-mail:2326791@qq.com
LI Cheng-yao, LI Pu. Research Progress of Common Gynecological Malignant Tumors to Preserve Fertility[J]. Journal of International Obstetrics and Gynecology, 2022, 49(2): 196-201.
Add to citation manager EndNote|Ris|BibTeX
[1] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi: 10.3322/caac.21660.
doi: 10.3322/caac.21660 |
[2] |
Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7):783-791. doi: 10.1097/CM9.0000000000001474.
doi: 10.1097/CM9.0000000000001474 |
[3] |
Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri[J]. Int J Gynaecol Obstet, 2018, 143(Suppl 2):22-36. doi: 10.1002/ijgo.12611.
doi: 10.1002/ijgo.12611 |
[4] | NCCN. NCCN Clinical Practice Guidelines in Oncology--Cervical Cancer[EB/OL]. Version 1. 2021. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. |
[5] |
Hartman CA, Teixeira JC, Barbosa SB, et al. Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years[J]. Int J Gynecol Cancer, 2017, 27(2):357-363. doi: 10.1097/IGC.0000000000000887.
doi: 10.1097/IGC.0000000000000887 |
[6] |
Miyakoshi K, Itakura A, Abe T, et al. Risk of preterm birth after the excisional surgery for cervical lesions: a propensity-score matching study in Japan[J]. J Matern Fetal Neonatal Med, 2021, 34(6):845-851. doi: 10.1080/14767058.2019.1619687.
doi: 10.1080/14767058.2019.1619687 |
[7] |
Zhang X, Tong J, Ma X, et al. Evaluation of cervical length and optimal timing for pregnancy after cervical conization in patients with cervical intraepithelial neoplasia: A retrospective study[J]. Medicine (Baltimore), 2020, 99(49):e23411. doi: 10.1097/MD.0000000000023411.
doi: 10.1097/MD.0000000000023411 |
[8] |
王延洲, 梁志清. 宫颈癌保留生育功能手术方案优化[J]. 中国临床医生杂志, 2020, 48(3):262-265. doi: 10.3969/j.issn.2095-8552.2020.03.004.
doi: 10.3969/j.issn.2095-8552.2020.03.004 |
[9] |
Sia TY, Chen L, Melamed A, et al. Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer[J]. Obstet Gynecol, 2019, 134(6):1132-1143. doi: 10.1097/AOG.0000000000003523.
doi: 10.1097/AOG.0000000000003523 |
[10] |
Feng Y, Zhang Z, Lou T, et al. The security of radical trachelectomy in the treatment of IA-IIA cervical carcinoma requires further evaluation: updated meta-analysis and trial sequential analysis[J]. Arch Gynecol Obstet, 2019, 299(6):1525-1536. doi: 10.1007/s00404-019-05141-9.
doi: 10.1007/s00404-019-05141-9 |
[11] |
Li X, Li J, Jiang Z, et al. Oncological results and recurrent risk factors following abdominal radical trachelectomy: an updated series of 333 patients[J]. BJOG, 2019, 126(9):1169-1174. doi: 10.1111/1471-0528.15621.
doi: 10.1111/1471-0528.15621 |
[12] |
Matsuo K, Chen L, Mandelbaum RS, et al. Trachelectomy for reproductive-aged women with early-stage cervical cancer: minimally invasive surgery versus laparotomy[J]. Am J Obstet Gynecol, 2019, 220(5):469.e1-e13. doi: 10.1016/j.ajog.2019.02.038.
doi: 10.1016/j.ajog.2019.02.038 |
[13] |
van Kol K, Vergeldt T, Bekkers R. Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates[J]. Gynecol Oncol,2019, 155(3):515-521. doi: 10.1016/j.ygyno.2019.09.025.
doi: 10.1016/j.ygyno.2019.09.025 |
[14] |
de Vincenzo R, Ricci C, Fanfani F, et al. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study[J]. Fertil Steril, 2021, 115(1):148-156. doi: 10.1016/j.fertnstert.2020.07.006.
doi: 10.1016/j.fertnstert.2020.07.006 pmid: 33092819 |
[15] |
Zusterzeel P, Aarts J, Pol F, et al. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer[J]. Oncologist,2020, 25(7):e1051-e1059. doi: 10.1634/theoncologist.2020-0063.
doi: 10.1634/theoncologist.2020-0063 |
[16] |
Feng Y, Zhang Z, Lou T, et al. The safety of fertility preservation for microinvasive cervical adenocarcinoma: a meta-analysis and trial sequential analysis[J]. Arch Gynecol Obstet, 2018, 298(3):465-475. doi: 10.1007/s00404-018-4799-0.
doi: 10.1007/s00404-018-4799-0 |
[17] |
Leone Roberti Maggiore U, Martinelli F, Dondi G, et al. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study[J]. J Gynecol Oncol, 2019, 30(4):e57. doi: 10.3802/jgo.2019.30.e57.
doi: 10.3802/jgo.2019.30.e57 |
[18] | 陈思敬, 郑莹. 子宫内膜癌保留生育功能指南解析[J]. 实用妇产科杂志, 2019, 35(12):905-909. |
[19] |
Novikova OV, Nosov VB, Panov VA, et al. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer[J]. Gynecol Oncol, 2021, 161(1):152-159. doi: 10.1016/j.ygyno.2021.01.001.
doi: 10.1016/j.ygyno.2021.01.001 pmid: 33461741 |
[20] |
Greenwald ZR, Huang LN, Wissing MD, et al. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?[J]. Cancer, 2017, 123(9):1545-1554. doi: 10.1002/cncr.30529.
doi: 10.1002/cncr.30529 pmid: 28026855 |
[21] |
Mitsuhashi A, Habu Y, Kobayashi T, et al. Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients[J]. J Gynecol Oncol, 2019, 30(6):e90. doi: 10.3802/jgo.2019.30.e90.
doi: 10.3802/jgo.2019.30.e90 |
[22] |
Acosta-Torres S, Murdock T, Matsuno R, et al. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates[J]. Gynecol Oncol, 2020, 157(2):348-356. doi: 10.1016/j.ygyno.2020.02.008.
doi: S0090-8258(20)30103-7 pmid: 32085863 |
[23] |
Wang Y, Yu M, Yang JX, et al. Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience[J]. Int J Clin Oncol, 2019, 24(6):712-720. doi: 10.1007/s10147-019-01404-2.
doi: 10.1007/s10147-019-01404-2 pmid: 30746595 |
[24] |
Masciullo V, Trivellizzi N, Zannoni G, et al. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate[J]. Am J Obstet Gynecol, 2021, 224(4):408-410. doi: 10.1016/j.ajog.2020.12.1210.
doi: 10.1016/j.ajog.2020.12.1210 pmid: 33385345 |
[25] |
Ribeiro CM, Brito L, Benetti-Pinto CL, et al. Is Diagnostic Hysteroscopy Safe for the Investigation of Type II Endometrial Cancer? A Retrospective Cohort Analysis[J]. J Minim Invasive Gynecol, 2021, 28(8):1536-1543. doi: 10.1016/j.jmig.2021.01.002.
doi: 10.1016/j.jmig.2021.01.002 |
[26] |
Kelly RA, Contos GT, Walker CA, et al. Hysteroscopic Morcellation in Endometrial Cancer Diagnosis: Increased Risk?[J]. J Minim Invasive Gynecol, 2021, 28(9):1625-1632. doi: 10.1016/j.jmig.2021.02.004.
doi: 10.1016/j.jmig.2021.02.004 |
[27] |
王益勤, 周蓉, 徐礼江, 等. 中分化Ⅰa期子宫内膜癌患者保留生育功能治疗的肿瘤结局和妊娠结局分析[J]. 中华妇产科杂志, 2020, 55(5):327-332. doi: 10.3760/cma.j.cn112141-20200118-00047.
doi: 10.3760/cma.j.cn112141-20200118-00047 |
[28] | NCCN. NCCN Clinical Practice Guidelines in Oncology--Uterine Neoplasms[EB/OL]. Version 1. 2021. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. |
[29] |
Chung YS, Woo HY, Lee JY, et al. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer[J]. Am J Obstet Gynecol, 2021, 224(4):370.e1-e13. doi: 10.1016/j.ajog.2020.10.003.
doi: 10.1016/j.ajog.2020.10.003 |
[30] |
卢淮武, 许妙纯, 张钰豪, 等. 《2021 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2021, 37(4):457-466. doi: 10.19538/j.fk2021040113.
doi: 10.19538/j.fk2021040113 |
[31] | NCCN. NCCN Clinical Practice Guidelines in Oncology--Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer[EB/OL]. Version 1. 2021. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. |
[32] |
中华医学会妇科肿瘤学分会. 妇科恶性肿瘤保留生育功能临床诊治指南[J]. 中华妇产科杂志, 2014, 49(4):243-248. doi: 10.3760/cma.j.issn.0529-567x.2014.04.002.
doi: 10.3760/cma.j.issn.0529-567x.2014.04.002 |
[33] |
Liu D, Cai J, Gao A, et al. Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival[J]. BMC Cancer, 2020, 20(1):320. doi: 10.1186/s12885-020-06828-y.
doi: 10.1186/s12885-020-06828-y |
[34] |
Crafton SM, Cohn DE, Llamocca EN, et al. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries[J]. Cancer, 2020, 126(6):1217-1224. doi: 10.1002/cncr.32620.
doi: 10.1002/cncr.32620 pmid: 31774553 |
[35] |
Liu H, Xu Y, Ji J, et al. Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population-based analysis[J]. Oncol Lett, 2020, 19(3):1947-1957. doi: 10.3892/ol.2020.11252.
doi: 10.3892/ol.2020.11252 |
[36] |
Kajiyama H, Suzuki S, Yoshikawa N, et al. Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma[J]. Arch Gynecol Obstet, 2019, 300(3):717-724. doi: 10.1007/s00404-019-05203-y.
doi: 10.1007/s00404-019-05203-y pmid: 31165243 |
[37] |
Morrison A, Nasioudis D. Reproductive outcomes following fertility-sparing surgery for malignant ovarian germ cell tumors: A systematic review of the literature[J]. Gynecol Oncol, 2020, 158(2):476-483. doi: 10.1016/j.ygyno.2020.05.036.
doi: S0090-8258(20)31121-5 pmid: 32513565 |
[38] |
Nasioudis D, Mastroyannis SA, Latif NA, et al. Trends in the surgical management of malignant ovarian germcell tumors[J]. Gynecol Oncol, 2020, 157(1):89-93. doi: 10.1016/j.ygyno.2020.01.033.
doi: 10.1016/j.ygyno.2020.01.033 |
[39] |
Newton C, Murali K, Ahmad A, et al. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice[J]. Eur J Cancer, 2019, 113:19-27. doi: 10.1016/j.ejca.2019.03.001.
doi: S0959-8049(19)30177-7 pmid: 30954883 |
[40] |
Tamauchi S, Kajiyama H, Yoshihara M, et al. Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study[J]. Am J Obstet Gynecol, 2018, 219(4):385.e1-e7. doi: 10.1016/j.ajog.2018.07.021.
doi: 10.1016/j.ajog.2018.07.021 |
[41] |
Chevrot A, Pouget N, Bats AS, et al. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group[J]. Gynecol Oncol, 2020, 157(1):29-35. doi: 10.1016/j.ygyno.2019.12.046.
doi: S0090-8258(19)31876-1 pmid: 32241341 |
[42] |
Jia SZ, Xiang Y, Yang JJ, et al. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study[J]. Hum Reprod, 2020, 35(2):328-339. doi: 10.1093/humrep/dez307.
doi: 10.1093/humrep/dez307 |
[43] |
Fang C, Zhao L, Chen X, et al. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors[J]. BMC Cancer, 2018, 18(1):1147. doi: 10.1186/s12885-018-4932-2.
doi: 10.1186/s12885-018-4932-2 |
[1] | GUO Jing, ZHANG Mao-xiang, ZHOU Chun-he, LIU Si-ning, LI Hui-yan. The Progress of Mendelian Randomization in the Study of the Causal Relationship between Exposure Factors and Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 169-174. |
[2] | CHAI Ling-na, LI Yan-li, SHI Jie, GAO Han, OUYANG Xi-yan, CHENG Shi-yu. Clinical Application of Indocyanine Green Tracing of Sentinel Lymph Nodes in Early Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 175-179. |
[3] | LIN Huan-yu, SHAO Xiao-guang, LU Xu-hong, WANG Qiu-yue, WEI Wei, TONG Chun-yan. Research Status and Hotspots of Fertility Preservation in Female Malignant Tumor Patients from 2004 to 2024 in the Web of Science Core Databases [J]. Journal of International Obstetrics and Gynecology, 2025, 52(2): 180-186. |
[4] | BAI Yao-jun, WANG Si-yao, LING Fei-fei, ZHANG Sen-huai, LI Hong-li, LIU Chang. Progress of Trop-2 and Targeted Trop-2 Antibody-Coupled Drugs in Gynecological Malignant Tumors [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 1-7. |
[5] | HU Ming-zhu, LIU Li-wen, HUANG Lei. The Relationship between Vaginal Microecology and Cervical Cancer in HIV-Infected Women [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 13-18. |
[6] | ZHANG Yun-feng, ZHANG Wan-yue, LU Yue, WANG Yang-yang, JING Jia-yu, MU Jing-yi, WANG Yue. Research Progress of ARID1A and PIK3CA Mutations in Malignant Transformation of Ovarian Endometriosis [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 19-22. |
[7] | LI Nan, PENG Er-xuan, LIU Feng-hua. Clinical Analysis of 20 Cases of Brain Metastasis from Ovarian Epithelial Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 23-27. |
[8] | JIA Yan-feng, WU Zhen-zhen, WANG Wei-hong, WANG Yue-yuan, LI Juan. A Case of Primary Ovarian Adenosquamous Carcinoma [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 32-36. |
[9] | SONG Li-fang, WU Zhen-zhen, MAO Bao-hong, ZHAO Xiao-li, LIU Qing. A Case of Isolated Lymph Node Metastasis from Ovarian Cancer to the Inguinal Region [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 37-41. |
[10] | ZHANG Ye, CHEN Qiao-yun, ZHAO Jia-yi, CHEN Lu, LIU Jian-rong. Progress in the Application of Nanoparticles in the Prevention and Treatment of Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 8-12. |
[11] | DOU Miao-miao, ZHENG Jing, ZHANG Hang, YANG Bo, ZHANG Chun-jie, LIU Zhi-jie. Diagnosis and Prognosis Analysis of Accessory Cavitated Uterine Malformations: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2025, 52(1): 84-88. |
[12] | LIU Si-min, LI Hong-li, GUO Xi, HU Ya-li, YANG Yong-xiu. Late Pregnancy with Ovarian Serous Cystadenoma Pedicle Torsion: A Case Report [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 632-635. |
[13] | WEI Jin-hua, QI Yu-chao, SHEN Xiao-ya. Analysis on the Incidence and Mortality of Cervical Cancer in China Based on the Age-Period-Cohort Model from 1992 to 2021 [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 664-668. |
[14] | LIU Yu, WU Rui-fang, LI Rui-zhen. A Case Report of Pregnancy after Radical Cervicectomy with Neoadjuvant Chemotherapy in Stage ⅠB2 Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 669-671. |
[15] | SONG Han, LIU Han-li, WANG Xi-bo. A Case of Soft Tissue Metastasis in the Back from Cervical Cancer [J]. Journal of International Obstetrics and Gynecology, 2024, 51(6): 672-675. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||